Showing results (71-80 of 319) with videos related to
Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407Ramaswamy Govindan, Jeffrey Bogart, Thomas Stinchcombe, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief reportArkadiusz Z Dudek, Herbert Pang, Robert A Kratzke, et al.International Journal of Oncology|November 18, 2004
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatmentNeil Mehta, Ann M Mauer, Samuel Hellman, et al.Head & Neck|September 6, 2019
A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancerRyan J Brisson, Sara Kochanny, Saba Arshad, et al.Investigational New Drugs|August 12, 2009
The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II ConsortiumHalla S Nimeiri, Deepti A Singh, Kristen Kasza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancerCharles M Rudin, Mark Kozloff, Philip C Hoffman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancerWalter M Stadler, Dingcai Cao, Nicholas J Vogelzang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431Everett E Vokes, James E Herndon, Jeffrey Crawford, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancerJerome D Winegarden, Ann M Mauer, Thomas F Gajewski, et al.International Journal of Radiation Oncology, Biology, Physics|February 13, 2007
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancerEzra E W Cohen, Dominique Rosine, Daniel J Haraf, et al.Pageof 32